drugset / Trial / NCT01344902
An Open Dose-finding Study of Oral Applied Hexaminolevulinate (HAL) Imaging in Patients With Suspicion or High Risk of Neoplasia in the Colon
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
The purpose of the study is to determine if it is possible to detect more pre-cancerous lesions in colon when using fluorescence technology.
Timeline
- Start
- 2009-02
- Primary completion
- 2009-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | hexaminolevulinate | Small molecule | 200 mg | Oral |